These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 620482)

  • 1. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isoniazid: influence of age.
    Kergueris MF; Bourin M; Larousse C
    Eur J Clin Pharmacol; 1986; 30(3):335-40. PubMed ID: 3732371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of isoniazid acetylation phenotypes in North Indians.
    Gupta RC; Nair CR; Jindal SK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of nonlinear disposition kinetics of sulfamethazine.
    du Souich P; Lalka D; Slaughter R; Elvin AT; McLean AJ
    Clin Pharmacol Ther; 1979 Feb; 25(2):172-83. PubMed ID: 759070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonazepam acetylation in fast and slow acetylators.
    Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.